Market Overview The pneumonia testing market is guiding targeted therapy selection through antimicrobial resistance detection identifying resistant pathogens before empirical treatment failure occurs. The Pneumonia Testing Market is projected to grow through 2030, driven by carbapenem-resistant organism screening, mecA gene detection, and extended-spectrum beta-lactamase identification...